Copyright © 2004, European Society of Cardiology
Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia
aInternal Medicine I, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Klinikum Großhadern, Marchioninistr. 15, 81377 Munich, Germany
bUnit of Pharmacology and Therapeutics, Department of Internal Medicine, UCL Medical School, Brussels, Belgium
* Corresponding author. Tel.: +49 89 7095 3075; fax: +49 89 7095 6075. Email address: christian.kupatt{at}med.uni-muenchen.de
Objective: Induction of angiogenesis has been reported subsequent to eNOS overexpression or activation, the latter involving Hsp90 as a chaperone protein. Here, we investigated the potential of regional Hsp90 overexpression to induce therapeutic neovascularization in vivo in a chronic rabbit hindlimb ischemia model.
Methods: In rabbits (n=7 per group), the external femoral artery was excised at day 0 (d0). At d7, liposomes containing eGFP (control group) or Hsp90 were retroinfused into the anterior tibial vein. At day 7 and day 35, angiographies were obtained and analyzed for collateral formation and perfusion velocity (frame count score) (% of d7 values). Capillary/muscle fiber (C/MF) ratio was calculated from five muscle areas of the ischemic limb. L-NAME and Geldanamycin were co-applied, where indicated.
Results: Compared to mock-treated controls, Hsp90 transfected increased C/MF ratio at day 35 (1.78 ± 0.15 vs. 1.19 ± 0.13, p<0.05), an effect blunted by L-NAME (1.39 ± 0.11). Hsp90 transfection increased collateral formation (157 ± 11% vs. 110 ± 13%) and frame count score (174 ± 18% vs. 117 ± 10%), both sensitive to inhibition by L-NAME coapplication (135 ± 17% and 134 ± 14%, respectively). Of note, C/MF ratio was found elevated 3 days after Hsp90 transfection (1.61 ± 0.16 at d10), at a time point when collateral formation was unchanged (106 ± 6%), and tended to remain elevated in the presence of L-NAME applied thereafter (1.64 ± 0.35 at d35), though L-NAME blocked subsequent changes in collateral growth or increase in perfusion at d35.
Conclusions: We conclude that Hsp90 is capable of inducing angiogenesis and arteriogenesis via nitric oxide (NO) in a rabbit model of chronic ischemia. Our findings describe the capillary level as an initial site of Hsp90-cDNA-induced neovascularization, followed by growth of larger conductance vessels, resulting in an improved hindlimb perfusion.
KEYWORDS Angiogenesis; Nitric oxide; Rabbit hindlimb ischemia; Gene therapy; Retroinfusion
Time for primary review 35 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. de Resende and A. S. Greene Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2814 - H2821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Baron-Menguy, A. Bocquet, A.-L. Guihot, D. Chappard, M.-J. Amiot, R. Andriantsitohaina, L. Loufrani, and D. Henrion Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic FASEB J, November 1, 2007; 21(13): 3511 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kupatt, R. Hinkel, M.-L. von Bruhl, T. Pohl, J. Horstkotte, P. Raake, C. El Aouni, E. Thein, S. Dimmeler, O. Feron, et al. Endothelial Nitric Oxide Synthase Overexpression Provides a Functionally Relevant Angiogenic Switch in Hibernating Pig Myocardium J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1575 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. de Resende, S. L. Amaral, D. H. Munzenmaier, and A. S. Greene Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake Physiol Genomics, April 13, 2006; 25(2): 325 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Post and J. Waltenberger Modulation of growth factor action in the cardiovascular system Cardiovasc Res, February 15, 2005; 65(3): 547 - 549. [Full Text] [PDF]
|
|